 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848719
Online Users : 1280
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/14564
|
| Title: | Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? |
| Authors: | Kuo, CL;Ponneri Babuharisankar, A;Lin, YC;Lien, HW;Lo, YK;Chou, HY;Tangeda, V;Cheng, LC;Cheng, AN;Lee, AY |
| Contributors: | National Institute of Cancer Research;NHRI Graduate Student Program |
| Abstract: | The major concept of "oxidative stress" is an excess elevated level of reactive oxygen species (ROS) which are generated from vigorous metabolism and consumption of oxygen. The precise harmonization of oxidative stresses between mitochondria and other organelles in the cell is absolutely vital to cell survival. Under oxidative stress, ROS produced from mitochondria and are the major mediator for tumorigenesis in different aspects, such as proliferation, migration/invasion, angiogenesis, inflammation, and immunoescape to allow cancer cells to adapt to the rigorous environment. Accordingly, the dynamic balance of oxidative stresses not only orchestrate complex cell signaling events in cancer cells but also affect other components in the tumor microenvironment (TME). Immune cells, such as M2 macrophages, dendritic cells, and T cells are the major components of the immunosuppressive TME from the ROS-induced inflammation. Based on this notion, numerous strategies to mitigate oxidative stresses in tumors have been tested for cancer prevention or therapies; however, these manipulations are devised from different sources and mechanisms without established effectiveness. Herein, we integrate current progress regarding the impact of mitochondrial ROS in the TME, not only in cancer cells but also in immune cells, and discuss the combination of emerging ROS-modulating strategies with immunotherapies to achieve antitumor effects. |
| Date: | 2022-09-26 |
| Relation: | Journal of Biomedical Science. 2022 Sep 26;29:Article number 74. |
| Link to: | http://dx.doi.org/10.1186/s12929-022-00859-2 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1021-7770&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000858689100001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85138571067 |
| Appears in Collections: | [李岳倫] 期刊論文
[其他] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB36154922.pdf | | 1341Kb | Adobe PDF | 173 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
